Synapse - Guenther Koehne

Search Within

Guenther Koehne

Results (194)

Pilot study to evaluate the prevalence of actionable oncogenic mutations in patients with relapsed refractory multiple myeloma

Meeting Abstract

Lesokhin, A.; Gonen, M.; Redling, K.; Lendvai, N.; Hassoun, H.; Landau, H.; Chung, D. J.; Koehne, G.; Patel, M.; Brennan, K. W.; more...
Blood (2013)

Fulltext@MSK | Save

T-cell depleted allogeneic hematopoietic stem cell transplantation for patients with relapsed multiple myeloma and high-risk cytogenetics permits long-lasting remissions in the absence of graft-versus-host disease

Meeting Abstract

Koehne, G.; Devlin, S. M.; Landau, H.; Hassoun, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Bravo, C.; Giralt, S.
Blood (2013)

Fulltext@MSK | Save

Two chemotherapy-based conditioning regimens compared to TBI-based conditioning secure consistent engraftment of T-cell depleted allogeneic HSCT, similarly low incidences of GVHD and favorable rates of disease-free survival (DFS)

Meeting Abstract

Koehne, G.; Boulad, F.; Klein, E. G.; Barker, J. N.; Castro-Malaspina, H. R.; Curran, K. J.; Giralt, S. A.; Goldberg, J. D.; Hasan, A. N.; Heller, G.; more...
Blood (2013)

Fulltext@MSK | Save

Generation and characterization of a third party GMP grade bank of CMV specific T-cells for adoptive immunotherapy of CMV infections in recipients of HSCT from cord blood or seronegative donors

Meeting Abstract

Hasan, A. N.; Doubrovina, E.; Koehne, G.; Prockop, S. E.; O'Reilly, R. J.
Blood (2013)

Fulltext@MSK | Save

Phase 1 trial of carfilzomib + high dose melphalan conditioning regimen prior to autologous hematopoietic stem cell transplantation (AHSCT) for relapsed multiple myeloma

Meeting Abstract

Costa, L. J.; Landau, H.; Venkata, J. K.; Kang, Y.; Koehne, G.; Chung, D. J.; Lendvai, N.; Bentz, T.; Giralt, S.
Blood (2013)

Fulltext@MSK | Save

T-cell depleted (TCD) hematopoietic stem cell transplantation (HCT) for adult patients with acute myelogenous leukemia (AML) In first and second remission: Long-term disease free survival (DFS) with a significantly reduced risk of graft-versus-host disease (GvHD)

Meeting Abstract

Ceberio, I.; Hilden, P.; Devlin, S. M.; Maloy, M.; Goldberg, J. D.; Perales, M. A.; Barker, J. N.; Castro-Malaspina, H.; Koehne, G.; Ponce, D. M.; more...
Blood (2013)

Fulltext@MSK | Save

Double-unit cord blood (CB) transplantation combined with haplo-identical CD34+ cell-selected PBSC results in 100% CB engraftment with enhanced myeloid recovery

Meeting Abstract

Barker, J. N.; Ponce, D. M.; Dahi, P. B.; Devlin, S.; Evans, K. L.; Lubin, M. N.; Meagher, R.; Reich, L.; Castro-Malaspina, H.; Goldberg, J. D.; more...
Blood (2013)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplantation for multiple myeloma: What place, if any?

Journal Article

Giralt, S.; Koehne, G.
Current Hematologic Malignancy Reports (2013)

Fulltext@MSK | Save

The emergence of WT1-specific t-cell responses following allogeneic T cell-depleted hematopoietic stem cell transplantation and low-dose donor lymphocyte infusions is associated with a graft- vs. -myeloma effect

Journal Article

Tyler, E. M.; Koehne, G.
OncoImmunology (2013)

Fulltext@MSK | Save

Final product composition after ex-vivo T-cell reduction: Miltenyi clinimacs versus baxter isolex 300i in a large cohort of allogeneic transplant patients

Meeting Abstract

Tonon, J.; Koehne, G.; Collins, N. H.; Malloy, M.; Chen, X.; Bleau, S.; Pessin, M.; Smith, K.; Maslak, P.; Devlin, S.; more...
Cytotherapy (2013)

Fulltext@MSK | Save